Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial : The Lancet

• Verify Information

  Please verify your information below and fill out all required fields marked in red.

• Contact Name *
• Specialty *
• Focus *
• Mobile Phone *
• Email *

Send Information